대구가톨릭대학교병원은 대구광역시 남구 두류공원로17길 33에 있는 대구가톨릭대학교 부속 종합병원이다.

During the past decade, Daegu Catholic University Medical Center conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 16 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 7 clinical trials were completed. i.e. 35% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Daegu Catholic University Medical Center" #1 sponsor was "Seung-Jung Park" with 25 trials, followed by "Daegu Catholic University Medical Center" with 17 trials sponsored, "Pfizer" with 8 trials sponsored, "Chong Kun Dang Pharmaceutical" with 4 trials sponsored and "Samsung Medical Center" with 4 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Daegu Catholic University Medical Center" #1 collaborator was "CardioVascular Research Foundation, Korea" with 28 trials as a collaborator, "Abbott" with 3 trials as a collaborator, "Ajou University School of Medicine" with 1 trials as a collaborator, "Amg Korea Co. Ltd." with 1 trials as a collaborator and "Biotronik Korea Co., Ltd" with 1 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Daegu Catholic University Medical Center" are "Coronary Artery Disease" (24 trials), "Hypertension" (6 trials), "Anesthesia, General" (3 trials), "Coronary Disease" (3 trials) and "Hepatocellular Carcinoma" (3 trials). Many other conditions were trialed in "Daegu Catholic University Medical Center" in a lesser frequency.

Most popular intervention types in "Daegu Catholic University Medical Center" are "Drug" (55 trials), "Device" (23 trials), "Procedure" (15 trials), "Biological" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Acupuncture" (3 trials), "0.75% ropivacaine" (2 trials), "Aspirin,Clopidogrel" (2 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Daegu Catholic University Medical Center" are 108 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Daegu Catholic University Medical Center". undefined are not yet recruiting, 17 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Daegu Catholic University Medical Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Daegu Catholic University Medical Center, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 14 trials that are defined as “Not Applicable".